WO2001068840A3 - REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM - Google Patents
REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM Download PDFInfo
- Publication number
- WO2001068840A3 WO2001068840A3 PCT/EP2001/002780 EP0102780W WO0168840A3 WO 2001068840 A3 WO2001068840 A3 WO 2001068840A3 EP 0102780 W EP0102780 W EP 0102780W WO 0168840 A3 WO0168840 A3 WO 0168840A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- regulation
- protein
- coa
- acyl
- binding inhibitor
- Prior art date
Links
- 101000929799 Homo sapiens Acyl-CoA-binding protein Proteins 0.000 title abstract 5
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 230000027455 binding Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2001250379A AU2001250379A1 (en) | 2000-03-14 | 2001-04-13 | Regulation of human diazepam binding inhibitor/acyl-coa-like protein |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18903800P | 2000-03-14 | 2000-03-14 | |
| US60/189,038 | 2000-03-14 | ||
| US25139300P | 2000-12-06 | 2000-12-06 | |
| US60/251,393 | 2000-12-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001068840A2 WO2001068840A2 (fr) | 2001-09-20 |
| WO2001068840A3 true WO2001068840A3 (fr) | 2002-03-07 |
Family
ID=26884722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2001/002780 WO2001068840A2 (fr) | 2000-03-14 | 2001-03-13 | REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001250379A1 (fr) |
| WO (1) | WO2001068840A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220096574A1 (en) * | 2019-01-29 | 2022-03-31 | Holobiome, Inc. | Methods and compositions for treating and preventing central nervous system disorders and other conditions caused by gut microbial dysbiosis |
| WO2025134073A2 (fr) * | 2023-12-22 | 2025-06-26 | Institut National de la Santé et de la Recherche Médicale | Méthodes et compositions pour le traitement de maladies ou d'affections induites par les corticostéroïdes, d'une inflammation synoviale et d'une maladie articulaire dégénérative |
| CN118141894A (zh) * | 2024-02-04 | 2024-06-07 | 河北医科大学 | Dbi及其水解产物肽在制备缓解外周神经疼痛药物中的应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998006847A1 (fr) * | 1996-08-16 | 1998-02-19 | Incyte Pharmaceuticals, Inc. | Proteine semblable a la dbi/acbp humaine |
| WO2001025436A2 (fr) * | 1999-10-05 | 2001-04-12 | Curagen Corporation | Polypeptides de type endozepine et polynucleotides codant ces derniers |
-
2001
- 2001-03-13 WO PCT/EP2001/002780 patent/WO2001068840A2/fr active Application Filing
- 2001-04-13 AU AU2001250379A patent/AU2001250379A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998006847A1 (fr) * | 1996-08-16 | 1998-02-19 | Incyte Pharmaceuticals, Inc. | Proteine semblable a la dbi/acbp humaine |
| WO2001025436A2 (fr) * | 1999-10-05 | 2001-04-12 | Curagen Corporation | Polypeptides de type endozepine et polynucleotides codant ces derniers |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE EM_HUM EMBL Heidelberg, Germany; 6 November 1999 (1999-11-06), ROWEN L ET AL.: "Sequencing of human chromosome 15 D15S146-D15S117 region", XP002182180 * |
| LIHRMANN I ET AL: "Frog diazepam-binding inhibitor: Peptide sequence, cDNA cloning, and expression in the brain.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 91, no. 15, 1994, 1994, pages 6899 - 6903, XP002182179, ISSN: 0027-8424 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001068840A2 (fr) | 2001-09-20 |
| AU2001250379A1 (en) | 2001-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9705039A (es) | Genes y proteinas de muerte celular programada. | |
| WO2002042445A3 (fr) | Cellules differenciees utilisables en therapie d'un individu humain | |
| WO2002020500A3 (fr) | Substances potentialisant un traitement anticancereux et methodes a cet effet | |
| WO2005030121A3 (fr) | Composes, compositions et procedes | |
| WO2004013310A3 (fr) | Methodes de diminution d'expression de gene cible in vivo par introduction d'arn interferant | |
| AU3307999A (en) | Phosphodiesterase 10 | |
| AU7548500A (en) | Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents | |
| D'Sa et al. | Tetrahydrobiopterin biosynthesis in C6 glioma cells: induction of GTP cyclohydrolase I gene expression by lipopolysaccharide and cytokine treatment | |
| AU2672099A (en) | Compositions and methods for wound healing | |
| WO2001093851A3 (fr) | Compositions et procedes pour traiter une affection neoplasique au moyen d'inhibiteurs de laminine 5 beta 3 | |
| WO2001068840A3 (fr) | REGULATION DE LA PROTEINE HUMAINE SEMBLABLE A ACYLE CoA/INHIBITEUR DE LIAISON DU DIAZEPAM | |
| WO2001019966A3 (fr) | Isolation de cellules souches derivees de muscle et utilisations associees | |
| WO2004003152A3 (fr) | Inhibiteurs de sos1 | |
| AU2001252181A1 (en) | Regulation of human lipoxin a4 receptor-like protein | |
| WO2001042431A3 (fr) | Regulation de la deformylase des mitochondries humaines | |
| AU3205600A (en) | Method and kit for early cancer prediction | |
| AU6113098A (en) | Compositions for treatment of disorders involving programmed cell death | |
| WO2001090160A3 (fr) | Regulation de la serine/threonine kinase humaine analogue a p78 | |
| WO2004000999A3 (fr) | Identification d'une migration regulee de recepteurs et metastase des cellules cancereuses de la peau | |
| WO2002101076A3 (fr) | Procedes d'expression ciblee d'un acide nucleique therapeutique | |
| CA2530663A1 (fr) | Regulation de kinase, 'regule en kinase bpco' (kinase rc) | |
| WO2003062197A3 (fr) | Inhibiteurs de nek2 | |
| WO2002000853A3 (fr) | Regulation de la protease de type caspase 1 humaine | |
| WO2002000854A3 (fr) | Regulation de l'enzyme humaine de type phosphodiesterase | |
| WO2002081705A3 (fr) | Regulation de la proteine humaine de type acetyltransferase gnat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |